Moderna has vaccinated the first participants in a trial for a Bundibugyo Ebola vaccine, as the Democratic Republic of Congo continues to battle its fastest-growing outbreak on record.

Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines indicatedPhase 1 trial is being conducted in Canada as part of…

Results may be months away, but efforts are advancing towards enhanced treatment and the world’s first vaccine for the Bundibugyo species of Ebola, the World Health Organization…